HARVARD BIOSCIENCE, INC. UNAUDITED PRO FORMA FINANCIAL INFORMATIONMerger Agreement • April 17th, 2018 • Harvard Bioscience Inc • Laboratory analytical instruments
On January 22, 2018, Harvard Bioscience, Inc., a company organized under the laws of Delaware (the “Company”), entered into a definitive merger agreement (the “Merger Agreement”) with Plymouth Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”) and Data Sciences International, Inc., a Delaware corporation (“DSI”), pursuant to which the Company would acquire DSI for approximately $70 million (subject to adjustment for net working capital and other customary adjustments, the “Merger Consideration”), by merging MergerCo with and into DSI, with DSI continuing as the surviving entity and wholly owned subsidiary of the Company (the “Merger”). On January 31, 2018, the Company completed its previously announced acquisition of DSI.
